Extracellular Matrix, a Hard Player in Angiogenesis

被引:158
作者
Mongiat, Maurizio [1 ]
Andreuzzi, Eva [1 ]
Tarticchio, Giulia [1 ]
Paulitti, Alice [1 ]
机构
[1] CRO IRCCS, Dept Translat Res, Expt Oncol Div 2, I-33081 Aviano, Italy
关键词
extracellular matrix; angiogenesis; tumor microenvironment; FIBROBLAST-GROWTH-FACTOR; HEPARAN-SULFATE PROTEOGLYCANS; RECOMBINANT HUMAN ENDOSTATIN; PERLECAN PROTEIN CORE; FACTOR RECEPTOR 2; ENDOTHELIAL-CELL PROLIFERATION; MOLECULAR-WEIGHT HYALURONAN; COLLAGEN TYPE-IV; TUMOR-GROWTH; IN-VITRO;
D O I
10.3390/ijms17111822
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The extracellular matrix (ECM) is a complex network of proteins, glycoproteins, proteoglycans, and polysaccharides. Through multiple interactions with each other and the cell surface receptors, not only the ECM determines the physical and mechanical properties of the tissues, but also profoundly influences cell behavior and many physiological and pathological processes. One of the functions that have been extensively explored is its impingement on angiogenesis. The strong impact of the ECM in this context is both direct and indirect by virtue of its ability to interact and/ or store several growth factors and cytokines. The aim of this review is to provide some examples of the complex molecular mechanisms that are elicited by these molecules in promoting or weakening the angiogenic processes. The scenario is intricate, since matrix remodeling often generates fragments displaying opposite effects compared to those exerted by the whole molecules. Thus, the balance will tilt towards angiogenesis or angiostasis depending on the relative expression of pro-or anti-angiogenetic molecules/ fragments composing the matrix of a given tissue. One of the vital aspects of this field of research is that, for its endogenous nature, the ECM can be viewed as a reservoir to draw from for the development of new more efficacious therapies to treat angiogenesis-dependent pathologies.
引用
收藏
页数:26
相关论文
共 249 条
[1]  
Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]
[2]   Glycosaminoglycans: key players in cancer cell biology and treatment [J].
Afratis, Nikos ;
Gialeli, Chrisostomi ;
Nikitovic, Dragana ;
Tsegenidis, Theodore ;
Karousou, Evgenia ;
Theocharis, Achilleas D. ;
Pavao, Mauro S. ;
Tzanakakis, George N. ;
Karamanos, Nikos K. .
FEBS JOURNAL, 2012, 279 (07) :1177-1197
[3]   Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells [J].
Aikawa, Takurna ;
Whipple, Chery A. ;
Lopez, Martha E. ;
Gunn, Jason ;
Young, Alison ;
Lander, Arthur D. ;
Korc, Murray .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (01) :89-99
[4]   Arresten, a Collagen-Derived Angiogenesis Inhibitor, Suppresses Invasion of Squamous Cell Carcinoma [J].
Aikio, Mari ;
Alahuhta, Ilkka ;
Nurmenniemi, Sini ;
Suojanen, Juho ;
Palovuori, Riitta ;
Teppo, Susanna ;
Sorsa, Timo ;
Lopez-Otin, Carlos ;
Pihlajaniemi, Taina ;
Salo, Tuula ;
Heljasvaara, Ritva ;
Nyberg, Pia .
PLOS ONE, 2012, 7 (12)
[5]   Transcriptome analysis of endothelial cell gene expression induced by growth on matrigel matrices: Identification and characterization of MAGP-2 and lumican as novel regulators of angiogenesis [J].
Albig A.R. ;
Roy T.G. ;
Becenti D.J. ;
Schiemann W.P. .
Angiogenesis, 2007, 10 (3) :197-216
[6]   Anti-vascular endothelial growth factor therapy for ocular neovascular disease [J].
Andreoli, Christopher M. ;
Miller, Joan W. .
CURRENT OPINION IN OPHTHALMOLOGY, 2007, 18 (06) :502-508
[7]   THROMBOSPONDIN SEQUENCE MOTIF (CSVTCG) IS RESPONSIBLE FOR CD36-BINDING [J].
ASCH, AS ;
SILBIGER, S ;
HEIMER, E ;
NACHMAN, RL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 182 (03) :1208-1217
[8]   Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin [J].
Astrof, Sophie ;
Crowley, Denise ;
Hynes, Richard O. .
DEVELOPMENTAL BIOLOGY, 2007, 311 (01) :11-24
[9]   Fibronectins in vascular morphogenesis [J].
Astrof, Sophie ;
Hynes, Richard O. .
ANGIOGENESIS, 2009, 12 (02) :165-175
[10]   MIGRATION AND PROLIFERATION OF ENDOTHELIAL CELLS IN PREFORMED AND NEWLY FORMED BLOOD-VESSELS DURING TUMOR ANGIOGENESIS [J].
AUSPRUNK, DH ;
FOLKMAN, J .
MICROVASCULAR RESEARCH, 1977, 14 (01) :53-65